Cape Investment Advisory’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48K | Sell |
27
-2
| -7% | -$110 | ﹤0.01% | 989 |
|
|
2025
Q1 | $2.05K | Buy |
29
+27
| +1,350% | +$1.91K | ﹤0.01% | 889 |
|
|
2024
Q4 | $131 | Sell |
2
-40
| -95% | -$2.62K | ﹤0.01% | 1073 |
|
|
2024
Q3 | $2.95K | Hold |
42
| – | – | ﹤0.01% | 784 |
|
|
2024
Q2 | $3.46K | Sell |
42
-136
| -76% | -$11.2K | ﹤0.01% | 729 |
|
|
2024
Q1 | $15.5K | Hold |
178
| – | – | 0.01% | 473 |
|
|
2023
Q4 | $17.2K | Buy |
178
+20
| +13% | +$1.93K | 0.01% | 565 |
|
|
2023
Q3 | $14K | Hold |
158
| – | – | 0.01% | 508 |
|
|
2023
Q2 | $13.7K | Buy |
158
+55
| +53% | +$4.77K | 0.01% | 498 |
|
|
2023
Q1 | $10K | Buy |
+103
| New | +$10K | 0.01% | 540 |
|